BRST5:Volunteer Assignments and Opportunities: Difference between revisions

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
[checked revision][checked revision]
← Older edit
VisualWikitext
No edit summary
No edit summary
 
(54 intermediate revisions by 4 users not shown)
Line 6: Line 6:


To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
 
__TOC__
<br />
<br />
{| class="wikitable" style="margin:auto"
{| class="wikitable" style="margin:auto"
Line 19: Line 19:
!'''Notes'''
!'''Notes'''
|-
|-
|CHAPTER 2 (EPITHELIAL TUMOURS OF THE )
|Disease
|
|
====CHAPTER 2 (EPITHELIAL TUMOURS OF THE BREAST)====
|
|
----
|
|
----
|
|
----
|
|
|-
----
|Usual Ductal Hyperplasia
|Disease
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|-
|Columnar Cell Lesions, Including Flat Epithelial Atypia||Disease||
|[[BRST5:Usual ductal hyperplasia|Usual ductal hyperplasia]]
|Disease
|
|
|
|
|
Line 44: Line 51:
|
|
|-
|-
|Atypical Ductal Hyperplasia||Disease||
|[[BRST5:Columnar cell lesions, including flat epithelial atypia|Columnar cell lesions, including flat epithelial atypia]]||Disease||
|
|
|
|
Line 53: Line 60:
|
|
|-
|-
|Sclerosing Adenosis||Disease||
|[[BRST5:Atypical ductal hyperplasia|Atypical ductal hyperplasia]]||Disease||
|
|
|
|
Line 62: Line 69:
|
|
|-
|-
|Apocrine Adenosis and Adenoma||Disease||
|[[BRST5:Sclerosing adenosis|Sclerosing adenosis]]||Disease||
|
|
|
|
Line 71: Line 78:
|
|
|-
|-
|Microglandular Adenosis||Disease||
|[[BRST5:Apocrine adenosis and adenoma|Apocrine adenosis and adenoma]]||Disease||
|
|
|
|
Line 80: Line 87:
|
|
|-
|-
|Radial Scar/Complex Sclerosing Lesion||Disease||
|[[BRST5:Microglandular adenosis|Microglandular adenosis]]||Disease||
|
|
|
|
Line 89: Line 96:
|
|
|-
|-
|Tubular Adenoma||Disease||
|[[BRST5:Radial scar / complex sclerosing lesion|Radial scar/complex sclerosing lesion]]||Disease||
|
|
|
|
Line 98: Line 105:
|
|
|-
|-
|Lactating Adenoma||Disease||
|[[BRST5:Tubular adenoma|Tubular adenoma]]||Disease||
|
|
|
|
Line 107: Line 114:
|
|
|-
|-
|Ductal Adenoma||Disease||
|[[BRST5:Lactating adenoma|Lactating adenoma]]||Disease||
|
|
|
|
Line 116: Line 123:
|
|
|-
|-
|Pleomorphic Adenoma||Disease||
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[BRST5:Ductal adenoma|Ductal adenoma]]||Disease||
|
|
|
|
Line 125: Line 143:
|
|
|-
|-
|Adenomyoepithelioma||Disease||
|[[BRST5:Pleomorphic adenoma|Pleomorphic adenoma]]||Disease||
|
|
|
|
Line 134: Line 152:
|
|
|-
|-
|Malignant Adenomyoepithelioma||Disease||
|[[BRST5:Adenomyoepithelioma|Adenomyoepithelioma]]||Disease||
|
|
|
|
Line 143: Line 161:
|
|
|-
|-
|Intraductal Papilloma||Disease||
|[[BRST5:Malignant adenomyoepithelioma|Malignant adenomyoepithelioma]]||Disease||
|
|
|
|
Line 152: Line 170:
|
|
|-
|-
|Papillary Ductal Carcinoma In Situ||Disease||
|[[BRST5:Intraductal papilloma|Intraductal papilloma]]||Disease||
|
|
|
|
Line 161: Line 179:
|
|
|-
|-
|Encapsulated Papillary Carcinoma||Disease||
|[[BRST5:Papillary ductal carcinoma in situ|Papillary ductal carcinoma in situ]]||Disease||
|
|
|
|
Line 170: Line 188:
|
|
|-
|-
|Solid Papillary Carcinoma (In Situ and Invasive)||Disease||
|[[BRST5:Encapsulated papillary carcinoma|Encapsulated papillary carcinoma]]||Disease||
|
|
|
|
Line 179: Line 197:
|
|
|-
|-
|Invasive Papillary Carcinoma||Disease||
|[[BRST5:Solid papillary carcinoma (in situ and invasive)|Solid papillary carcinoma (in situ and invasive)]]||Disease||
|
|
|
|
Line 188: Line 206:
|
|
|-
|-
|Atypical Lobular Hyperplasia||Disease||
|[[BRST5:Invasive papillary carcinoma|Invasive papillary carcinoma]]||Disease||
|
|
|
|
Line 197: Line 215:
|
|
|-
|-
|Lobular Carcinoma In Situ||Disease||
|[[BRST5:Atypical lobular hyperplasia|Atypical lobular hyperplasia]]||Disease||
|
|
|
|
Line 206: Line 224:
|
|
|-
|-
|Ductal Carcinoma In Situ||Disease||
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[BRST5:Lobular carcinoma in situ|Lobular carcinoma in situ]]||Disease||
|
|
|
|
Line 215: Line 244:
|
|
|-
|-
|Invasive Breast Carcinoma of No Special Type||Disease||
|[[BRST5:Ductal carcinoma in situ|Ductal carcinoma in situ]]||Disease||
|
|
|
|
Line 224: Line 253:
|
|
|-
|-
|Microinvasive Carcinoma||Disease||
|[[BRST5:Invasive breast carcinoma of no special type|Invasive breast carcinoma of no special type]]||Disease||
|
|
|
|
|
|
|
|
|
|
|-
|[[BRST5:Microinvasive carcinoma|Microinvasive carcinoma]]||Disease||Hieu Nguyen
|9/23/2025
|
|
|PENDING
|
|
|Katherine Geiersbach
|
|
|
|
|-
|-
|Invasive lobular Carcinoma||Disease||
|[[BRST5:Invasive lobular carcinoma|Invasive lobular carcinoma]]||Disease||
|
|
|
|
Line 242: Line 280:
|
|
|-
|-
|Tubular Carcinoma||Disease||
|[[BRST5:Tubular carcinoma|Tubular carcinoma]]||Disease||
|
|
|
|
Line 251: Line 289:
|
|
|-
|-
|Cribriform Carcinoma||Disease||
|[[BRST5:Cribriform carcinoma|Cribriform carcinoma]]||Disease||
|
|
|
|
Line 260: Line 298:
|
|
|-
|-
|Mucinous Carcinoma||Disease||
|[[BRST5:Mucinous carcinoma|Mucinous carcinoma]]||Disease||
|
|
|
|
Line 269: Line 307:
|
|
|-
|-
|Mucinous Cystadenocarcinoma||Disease||
|[[BRST5:Mucinous cystadenocarcinoma|Mucinous cystadenocarcinoma]]||Disease||
|
|
|
|
Line 278: Line 316:
|
|
|-
|-
|Invasive Micropapillary Carcinoma||Disease||
|[[BRST5:Invasive micropapillary carcinoma|Invasive micropapillary carcinoma]]||Disease||
|
|
|
|
Line 287: Line 325:
|
|
|-
|-
|Carcinoma with Apocrine Differentiation||Disease||
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[BRST5:Carcinoma with apocrine differentiation|Carcinoma with apocrine differentiation]]||Disease||
|
|
|
|
Line 296: Line 345:
|
|
|-
|-
|Metaplastic Carcinoma||Disease||
|[[BRST5:Metaplastic carcinoma|Metaplastic carcinoma]]||Disease||
|
|
|
|
Line 305: Line 354:
|
|
|-
|-
|Acinic Cell Carcinoma||Disease||
|[[BRST5:Acinic cell carcinoma|Acinic cell carcinoma]]||Disease||
|
|
|
|
Line 314: Line 363:
|
|
|-
|-
|[[Adenoid Cystic Carcinoma]]||Disease||Katherine Geiersbach / Jun Liao
|[[BRST5:Adenoid cystic carcinoma|Adenoid cystic carcinoma]]||Disease||Katherine Geiersbach;
Jun Liao
|10/12/02022
|10/12/02022
|11/11/2023
|11/11/2023
|COMPLETE
|COMPLETE
|
|
|Hui Chen / Katherine Geiersbach
|Katherine Geiersbach
|12/6/2023
|4/16/2025
|2021 template added
|2024 template added
|-
|-
|[[Secretory Carcinoma]]||Disease||Hui Chen / Morteza Seifi
|[[BRST5:Secretory carcinoma|Secretory carcinoma]]||Disease||Hui Chen;
Katherine Geiersbach
|10/12/2022
|10/12/2022
|11/11/2023
|11/11/2023
|PENDING
|COMPLETE
|
|
|Katherine Geiersbach
|Katherine Geiersbach
|
|4/16/2025
|2021 template added
|2024 template added
|-
|-
|Mucoepidermoid Carcinoma||Disease||
|[[BRST5:Mucoepidermoid carcinoma|Mucoepidermoid carcinoma]]||Disease||
|
|
|
|
Line 341: Line 392:
|
|
|-
|-
|Polymorphous Adenocarcinoma||Disease||
|[[BRST5:Polymorphous adenocarcinoma|Polymorphous adenocarcinoma]]||Disease||
|
|
|
|
Line 350: Line 401:
|
|
|-
|-
|[[Tall Cell Carcinoma with Reversed Polarity]]||Disease||H. Evin Gulbahce
|[[BRST5:Tall cell carcinoma with reversed polarity|Tall cell carcinoma with reversed polarity]]||Disease||H. Evin Gulbahce
|8/11/2023
|8/11/2023
|10/11/2023
|10/11/2023
Line 356: Line 407:
|
|
|Katherine Geiersbach
|Katherine Geiersbach
|4/16/2025
|2024 template added
|-
|[[BRST5:Neuroendocrine tumour|Neuroendocrine tumour]]||Disease||
|
|
|
|
|
|
|
|
|2021 template added
|-
|-
|Neuroendocrine Tumour||Disease||
|[[BRST5:Neuroendocrine carcinoma|Neuroendocrine carcinoma]]||Disease||
|
|
|
|
Line 368: Line 428:
|
|
|-
|-
|Neuroendocrine Carcinoma||Disease||
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|
====CHAPTER 3 (FIBROEPITHELIAL TUMOURS AND HAMARTOMAS OF THE BREAST)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
----
|
----
|-
|-
|Hamartoma||Disease||
|[[BRST5:Hamartoma|Hamartoma]]||Disease||
|
|
|
|
Line 386: Line 469:
|
|
|-
|-
|[[Fibroadenoma]]||Disease||H. Evin Gulbahce / Patricija Zot
|[[BRST5:Fibroadenoma|Fibroadenoma]]|| ||
|8/11/2023
|
|11/11/2023
|
|PENDING
|
|
|
|
|
|
|
|
|2021 template added
|-
|-
|[[Phyllodes Tumour]]||Disease||Emilie Lalonde / H. Evin Gulbahce /Katherine Geiersbach
|[[BRST5:Phyllodes tumour|Phyllodes tumour]]||Disease||Emilie Lalonde;
H. Evin Gulbahce;
 
Katherine Geiersbach
|8/11/2023
|8/11/2023
|11/11/2023
|11/11/2023
Line 401: Line 487:
|
|
|
|
|1/8/2025
|2024 template added
|-
|
====CHAPTER 4 (TUMOURS OF THE NIPPLE)====
|
----
|
|
|2021 template added
----
|-
|Syringomatous Tumour||Disease||
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|-
|Nipple Adenoma||Disease||
|[[BRST5:Syringomatous tumour|Syringomatous tumour]]||Disease||
|
|
|
|
Line 422: Line 520:
|
|
|-
|-
|Paget disease of the Breast||Disease||
|[[BRST5:Nipple adenoma|Nipple adenoma]]||Disease||
|
|
|
|
Line 431: Line 529:
|
|
|-
|-
|Haemangioma||Disease||
|[[BRST5:Paget disease of the breast|Paget disease of the breast]]||Disease||
|
|
|
|
Line 440: Line 538:
|
|
|-
|-
|Angiomatosis||Disease||
|
|
====CHAPTER 5 (MESENCHYMAL TUMOURS OF THE BREAST)====
|
----
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
----
|-
|-
|Atypical Vascular Lesions||Disease||
|[[BRST5:Haemangioma|Haemangioma]]||Disease||
|
|
|
|
Line 458: Line 568:
|
|
|-
|-
|Postradiation Angiosarcoma of the Breast||Disease||
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[BRST5:Angiomatosis|Angiomatosis]]||Disease||
|
|
|
|
Line 467: Line 588:
|
|
|-
|-
|Primary Angiosarcoma of the Breast||Disease||
|[[BRST5:Atypical vascular lesions|Atypical vascular lesions]]||Disease||
|
|
|
|
Line 476: Line 597:
|
|
|-
|-
|Nodular Fasciitis||Disease||
|[[BRST5:Postradiation angiosarcoma of the breast|Postradiation angiosarcoma of the breast]]||Disease||
|
|
|
|
Line 485: Line 606:
|
|
|-
|-
|Myofibroblastoma||Disease||
|[[BRST5:Primary angiosarcoma of the breast|Primary angiosarcoma of the breast]]||Disease||
|
|
|
|
Line 494: Line 615:
|
|
|-
|-
|Desmoid Fibromatosis||Disease||
|[[BRST5:Nodular fasciitis|Nodular fasciitis]]||Disease||
|
|
|
|
Line 503: Line 624:
|
|
|-
|-
|[[Inflammatory Myofibroblastic Tumour]]||Disease||Yajuan Liu
|[[BRST5:Myofibroblastoma|Myofibroblastoma]]||Disease||
|8/11/2023
|11/11/2023
|COMPLETE
|
|Katherine Geiersbach
|12/6/2023
|2021 template added
|-
|Schwannoma||Disease||
|
|
|
|
Line 521: Line 633:
|
|
|-
|-
|Neurofibroma||Disease||
|[[BRST5:Desmoid fibromatosis|Desmoid fibromatosis]]||Disease||
|
|
|
|
Line 530: Line 642:
|
|
|-
|-
|Granular Cell Tumour||Disease||
|[[BRST5:Inflammatory myofibroblastic tumour|Inflammatory myofibroblastic tumour]]||Disease||Katherine Geiersbach
|8/11/2023
|11/11/2023
|COMPLETE
|
|Katherine Geiersbach
|1/8/2025
|2024 template
|-
|[[BRST5:Schwannoma|Schwannoma]]||Disease||
|
|
|
|
Line 539: Line 660:
|
|
|-
|-
|Leiomyoma||Disease||
|[[BRST5:Neurofibroma|Neurofibroma]]||Disease||
|
|
|
|
Line 548: Line 669:
|
|
|-
|-
|Leiomyosarcoma||Disease||
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[BRST5:Granular cell tumour|Granular cell tumour]]||Disease||
|
|
|
|
Line 557: Line 689:
|
|
|-
|-
|Lipoma||Disease||
|[[BRST5:Leiomyoma|Leiomyoma]]||Disease||
|
|
|
|
Line 566: Line 698:
|
|
|-
|-
|Angiolipoma||Disease||
|[[BRST5:Leiomyosarcoma|Leiomyosarcoma]]||Disease||
|
|
|
|
Line 575: Line 707:
|
|
|-
|-
|Liposarcoma||Disease||
|[[BRST5:Lipoma|Lipoma]]||Disease||
|
|
|
|
Line 584: Line 716:
|
|
|-
|-
|Pseudoangiomatous Stromal Hyperplasia||Disease||
|[[BRST5:Angiolipoma|Angiolipoma]]||Disease||
|
|
|
|
Line 593: Line 725:
|
|
|-
|-
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease||
|[[BRST5:Liposarcoma|Liposarcoma]]||Disease||
|
|
|
|
Line 602: Line 734:
|
|
|-
|-
|Follicular Lymphoma||Disease||
|[[BRST5:Pseudoangiomatous stromal hyperplasia|Pseudoangiomatous stromal hyperplasia]]||Disease||
|
|
|
|
Line 611: Line 743:
|
|
|-
|-
|Diffuse Large B-cell Lymphoma||Disease||
|
|
====CHAPTER 6 (HAEMATOLYMPHOID TUMOURS OF THE BREAST)====
|
----
|
----
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|-
|Burkitt Lymphoma||Disease||
|[[BRST5:Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)|Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)]]||Disease||[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|
|
|
|
Line 629: Line 773:
|
|
|-
|-
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||
|[[BRST5:Follicular lymphoma|Follicular lymphoma]]||Disease||[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|
|
|
|
Line 638: Line 782:
|
|
|-
|-
|Gynaecomastia||Disease||
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[BRST5:Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma]]||Disease||[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|
|
|
|
Line 647: Line 802:
|
|
|-
|-
|Carcinoma In Situ||Disease||
|[[BRST5:Burkitt lymphoma|Burkitt lymphoma]]||Disease||[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|
|
|
|
Line 656: Line 811:
|
|
|-
|-
|Invasive Carcinoma||Disease||
|[[BRST5:Breast implant-associated anaplastic large cell lymphoma|Breast implant-associated anaplastic large cell lymphoma]]||Disease||
|
|
|
|
Line 665: Line 820:
|
|
|-
|-
|Metastases to the Breast||Disease||
|
|
====CHAPTER 7 (TUMOURS OF THE MALE BREAST)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome||Disease||Constance Albarracin / Katherine Geiersbach
|12/6/2023
|3/6/2024
|
|
----
|
|
|Katherine Geiersbach
----
|
|
|NOT YET CREATED - See page "[[BRCA-Related Cancer Predisposition Syndrome (BRCA1, BRCA2)]]" in GTS5 book. Will later add breast book link redirecting to this GTS5 book page (need to correlate with related volunteer page - [[GTS5:Volunteer Assignments and Opportunities]]).
----
|-
|-
|Cowden Syndrome||Disease||
|[[BRST5:Gynaecomastia|Gynaecomastia]]||Disease||
|
|
|
|
|
Line 690: Line 849:
|
|
|
|
|NOT YET CREATED - See page "[[Cowden Syndrome]]" in GTS5 book. Will later add breast book link redirecting to this DIG5 book page (need to correlate with related volunteer page - [[DIG5:Volunteer Assignments and Opportunities]]).
|-
|-
|Ataxia-Telangiectasia||Disease||Evin Gulbahce / Katherine Geiersbach
|[[BRST5:Carcinoma in situ|Carcinoma in situ]]||Disease||
|12/11/2023
|3/11/2024
|
|
|Katherine Geiersbach
|
|
|NOT YET CREATED - See page "[[Ataxia-Telangiectasia Syndrome (ATM)]]" in GTS5 book. Will later add breast book link redirecting to this GTS5 book page (need to correlate with related volunteer page - [[GTS5:Volunteer Assignments and Opportunities]]).
|-
|Li-Fraumeni Syndrome, TP53-Associated||Disease||
|
|
|
|
Line 708: Line 858:
|
|
|
|
|NOT YET CREATED - See page "[[Li-Fraumeni Syndrome (TP53)]]" in GTS5 book. Will later add breast book link redirecting to this GTS5 book page (need to correlate with related volunteer page - [[GTS5:Volunteer Assignments and Opportunities]]).
|-
|-
|Li-Fraumeni Syndrome, CHEK2-Associated||Disease||
|[[BRST5:Invasive carcinoma|Invasive carcinoma]]||Disease||
|
|
|
|
|
Line 717: Line 867:
|
|
|
|
|NOT YET CREATED - See page "[[CHEK2-Related Hereditary (Breast) Cancer Predisposition Syndrome (CHEK2)]]" in GTS5 book. Will later add breast book link redirecting to this GTS5 book page (need to correlate with related volunteer page - [[GTS5:Volunteer Assignments and Opportunities]]).
|-
|-
|CDH1-Associated Breast Cancer||Disease||
|[[BRST5:Metastases to the breast|Metastases to the breast]]||Disease||
|
|
|
|
|
|
|
|
|
|
|NOT YET CREATED - See page "[[Hereditary Gastric and Breast Cancer Syndrome (CDH1, CTNNA1)]]" in GTS5 book. Will later add breast book link redirecting to this GTS5 book page (need to correlate with related volunteer page - [[GTS5:Volunteer Assignments and Opportunities]]).
|-
|PALB2-Associated Cancers||Disease||Jun Liao / Constance Albarracin / Katherine Geiersbach
|12/8/2023
|3/8/2024
|
|
|
|
|Katherine Geiersbach
|
|
|NOT YET CREATED - See page "[[PALB2-Related Cancer Predisposition Syndrome (PALB2)]]" in GTS5 book. Will later add breast book link redirecting to this GTS5 book page (need to correlate with related volunteer page - [[GTS5:Volunteer Assignments and Opportunities]]).
|-
|-
|Peutz-Jeghers Syndrome||Disease||
|
|
====CHAPTER 8 (GENETIC TUMOUR SYNDROMES OF THE BREAST)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|NOT YET CREATED - See page "[[Peutz-Jeghers Syndrome (STK11)]]" in GTS5 book. Will later add breast book link redirecting to this GTS5 book page (need to correlate with related volunteer page - [[GTS5:Volunteer Assignments and Opportunities]]).
----
|-
|Neurofibromatosis Type 1||Disease||Ngoni Faya (trainee) + Madina Sukhanova
|
|
----
|
|
----
|
|
----
|
|
|
----
|
|-
|NOT YET CREATED - See page "[[Neurofibromatosis Type 1 (NF1)]]" in GTS5 book. Will later add breast book link redirecting to this GTS5 book page (need to correlate with related volunteer page - [[GTS5:Volunteer Assignments and Opportunities]]).
|[[BRST5:BRCA1/2-associated hereditary breast and ovarian cancer syndrome|BRCA1/2-associated hereditary breast and ovarian cancer syndrome]]||Disease||[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|-
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[BRST5:Cowden syndrome|Cowden syndrome]]||Disease||[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship statu]]<nowiki/>s [see [[GTS5:PTEN hamartoma tumour syndrome (PTEN)|PTEN hamartoma tumour syndrome (PTEN)]]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|[[BRST5:Ataxia-telangiectasia|Ataxia-telangiectasia]]||Disease||[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|[[BRST5:Li-Fraumeni syndrome, TP53-associated|Li-Fraumeni syndrome, TP53-associated]]||Disease||[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|[[BRST5:Li-Fraumeni syndrome, CHEK2-associated|Li-Fraumeni syndrome, CHEK2-associated]]||Disease||[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|[[BRST5:CDH1-associated breast cancer|CDH1-associated breast cancer]]||Disease||[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|[[BRST5:PALB2-associated cancers|PALB2-associated cancers]]||Disease||[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|[[BRST5:Peutz-Jeghers syndrome|Peutz-Jeghers syndrome]]||Disease||[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|[[GTS5:Neurofibromatosis type 1 (NF1)|Neurofibromatosis type 1]]||Disease||[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|-
|[[Polygenic Component of Breast Cancer Susceptibility]]
|[[BRST5:Polygenic component of breast cancer susceptibility|Polygenic component of breast cancer susceptibility]]
|Disease
|Disease
|Xiaolin Hu
|6/4/2024
|
|
|
|
Line 762: Line 999:
|
|
|
|
|
|Template added (6/4/24)
|
|Template added (12/30/23)
|-
|-
|}<br />
|}<br />

Latest revision as of 09:39, 1 October 2025

Welcome!

For assignments, please see the "Author" column below (highlighted blue).

If empty (no name is present), please volunteer to create content for that disease!

To volunteer, please [Contact us] with your page of interest.


WHO Classification of Tumours of the Breast (5th Edition) Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes

CHAPTER 2 (EPITHELIAL TUMOURS OF THE BREAST)
Usual ductal hyperplasia Disease
Columnar cell lesions, including flat epithelial atypia Disease
Atypical ductal hyperplasia Disease
Sclerosing adenosis Disease
Apocrine adenosis and adenoma Disease
Microglandular adenosis Disease
Radial scar/complex sclerosing lesion Disease
Tubular adenoma Disease
Lactating adenoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Ductal adenoma Disease
Pleomorphic adenoma Disease
Adenomyoepithelioma Disease
Malignant adenomyoepithelioma Disease
Intraductal papilloma Disease
Papillary ductal carcinoma in situ Disease
Encapsulated papillary carcinoma Disease
Solid papillary carcinoma (in situ and invasive) Disease
Invasive papillary carcinoma Disease
Atypical lobular hyperplasia Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Lobular carcinoma in situ Disease
Ductal carcinoma in situ Disease
Invasive breast carcinoma of no special type Disease
Microinvasive carcinoma Disease Hieu Nguyen 9/23/2025 PENDING Katherine Geiersbach
Invasive lobular carcinoma Disease
Tubular carcinoma Disease
Cribriform carcinoma Disease
Mucinous carcinoma Disease
Mucinous cystadenocarcinoma Disease
Invasive micropapillary carcinoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Carcinoma with apocrine differentiation Disease
Metaplastic carcinoma Disease
Acinic cell carcinoma Disease
Adenoid cystic carcinoma Disease Katherine Geiersbach;

Jun Liao

10/12/02022 11/11/2023 COMPLETE Katherine Geiersbach 4/16/2025 2024 template added
Secretory carcinoma Disease Hui Chen;

Katherine Geiersbach

10/12/2022 11/11/2023 COMPLETE Katherine Geiersbach 4/16/2025 2024 template added
Mucoepidermoid carcinoma Disease
Polymorphous adenocarcinoma Disease
Tall cell carcinoma with reversed polarity Disease H. Evin Gulbahce 8/11/2023 10/11/2023 COMPLETE Katherine Geiersbach 4/16/2025 2024 template added
Neuroendocrine tumour Disease
Neuroendocrine carcinoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes

CHAPTER 3 (FIBROEPITHELIAL TUMOURS AND HAMARTOMAS OF THE BREAST)
Hamartoma Disease
Fibroadenoma
Phyllodes tumour Disease Emilie Lalonde;

H. Evin Gulbahce;

Katherine Geiersbach

8/11/2023 11/11/2023 COMPLETE 1/8/2025 2024 template added

CHAPTER 4 (TUMOURS OF THE NIPPLE)
Syringomatous tumour Disease
Nipple adenoma Disease
Paget disease of the breast Disease

CHAPTER 5 (MESENCHYMAL TUMOURS OF THE BREAST)
Haemangioma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Angiomatosis Disease
Atypical vascular lesions Disease
Postradiation angiosarcoma of the breast Disease
Primary angiosarcoma of the breast Disease
Nodular fasciitis Disease
Myofibroblastoma Disease
Desmoid fibromatosis Disease
Inflammatory myofibroblastic tumour Disease Katherine Geiersbach 8/11/2023 11/11/2023 COMPLETE Katherine Geiersbach 1/8/2025 2024 template
Schwannoma Disease
Neurofibroma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Granular cell tumour Disease
Leiomyoma Disease
Leiomyosarcoma Disease
Lipoma Disease
Angiolipoma Disease
Liposarcoma Disease
Pseudoangiomatous stromal hyperplasia Disease

CHAPTER 6 (HAEMATOLYMPHOID TUMOURS OF THE BREAST)
Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) Disease See HAEM5 volunteer sheet for authorship status
Follicular lymphoma Disease See HAEM5 volunteer sheet for authorship status
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Diffuse large B-cell lymphoma Disease See HAEM5 volunteer sheet for authorship status
Burkitt lymphoma Disease See HAEM5 volunteer sheet for authorship status
Breast implant-associated anaplastic large cell lymphoma Disease

CHAPTER 7 (TUMOURS OF THE MALE BREAST)
Gynaecomastia Disease
Carcinoma in situ Disease
Invasive carcinoma Disease
Metastases to the breast Disease

CHAPTER 8 (GENETIC TUMOUR SYNDROMES OF THE BREAST)
BRCA1/2-associated hereditary breast and ovarian cancer syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Cowden syndrome Disease See GTS5 volunteer sheet for authorship status [see PTEN hamartoma tumour syndrome (PTEN)] N/A N/A N/A N/A N/A N/A N/A
Ataxia-telangiectasia Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Li-Fraumeni syndrome, TP53-associated Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Li-Fraumeni syndrome, CHEK2-associated Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
CDH1-associated breast cancer Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
PALB2-associated cancers Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Peutz-Jeghers syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Neurofibromatosis type 1 Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Polygenic component of breast cancer susceptibility Disease Xiaolin Hu 6/4/2024 Template added (6/4/24)


Retrieved from "https://test.ccga.io/index.php?title=BRST5:Volunteer_Assignments_and_Opportunities&oldid=19369"